LifeMD, Inc.·4

Jun 14, 8:55 AM ET

Velge Bertrand 4

4 · LifeMD, Inc. · Filed Jun 14, 2023

Insider Transaction Report

Form 4
Period: 2023-06-07
Transactions
  • Purchase

    Common Stock

    2023-06-07$2.19/sh+24,500$53,547164,000 total(indirect: By LLC)
  • Purchase

    Common Stock

    2023-06-13$2.64/sh+44,365$116,933208,365 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By LLC)
    916,666
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.59 to $2.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT